Animal models of HIV peripheral neuropathy

Future Virology

Volumn 9, Issue 5, 2014, Pages 465-474

  Burdo, Tricia H ^a   Miller, Andrew D ^b  

^a BOSTON COLLEGE   (United States)

^b Department of Obstetrics Gynecology   (United States)

Author keywords

acquired immunodeficiency syndrome; animal models; antiretroviral agents; HIV neuropathy; HIV 1; macrophage; peripheral nervous system diseases; sensory neuropathy

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AIDS PATIENT; ANIMAL MODEL; ANTIVIRAL THERAPY; ASTROCYTOSIS; FELINE MODEL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOLOGY; MACACA NEMESTRINA; MOUSE MODEL; NERVE CELL DEGENERATION; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; OPPORTUNISTIC INFECTION; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RABBIT MODEL; RAT MODEL; REVIEW; RHESUS MONKEY; SENSORY NEUROPATHY; SPINAL GANGLION; VIRUS ENCEPHALITIS;

EID: 84902513671     PISSN: 17460794     EISSN: 17460808     Source Type: Journal    
DOI: 10.2217/fvl.14.28     Document Type: Review

References (86)

1. Ferrari S Vento S Monaco S et al. Human immunodeficiency virus-associated peripheral neuropathies. Mayo Clin. Proc. 81(2) 213-219 (2006
2. Simpson DM. Selected peripheral neuropathies associated with human immunodeficiency virus infection and antiretroviral therapy. J. Neurovirol. 8(Suppl. 2) 33-41 (2002
3. Ellis RJ Rosario D Clifford DB et al. Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER study. Arch. Neurol. 67(5) 552-558 (2010
4. Ghosh S Chandran A Jansen JP. Epidemiology of HIV-related neuropathy: a systematic literature review. AIDS Res. Hum. Retroviruses 28(1) 36-48 (2012
5. Keswani SC Polley M Pardo CA Griffin JW McArthur JC Hoke A. Schwann cell chemokine receptors mediate HIV-1 gp120 toxicity to sensory neurons. Ann. Neurol. 54(3) 287-296 (2003
6. Gonzalez-Duarte A Robinson-Papp J Simpson DM. Diagnosis and management of HIV-associated neuropathy. Neurol. Clin. 26(3) 821-832 (2008
7. Letendre SL Ellis RJ Everall I Ances B Bharti A McCutchan JA. Neurologic complications of HIV disease and their treatment. Top. HIV Med. 17(2) 46-56 (2009
8. Ellis RJ Marquie-Beck J Delaney P et al. Human immunodeficiency virus protease inhibitors and risk for peripheral neuropathy. Ann. Neurol. 64(5) 566-572 (2008
9. Kamerman PR Wadley AL Cherry CL. HIV-associated sensory neuropathy: risk factors and genetics. Curr. Pain Headache Rep. 16(3) 226-236 (2012
10. Smyth K Affandi JS McArthur JC et al. Prevalence of and risk factors for HIVassociated neuropathy in Melbourne Australia 1993-2006. HIV Med. 8(6) 367-373 (2007
11. Gibbons CH Griffin JW Polydefkis M et al. The utility of skin biopsy for prediction of progression in suspected small fiber neuropathy. Neurology 66(2) 256-258 (2006
12. Herrmann DN Griffin JW Hauer P Cornblath DR McArthur JC. Epidermal nerve fiber density and sural nerve morphometry in peripheral neuropathies. Neurology 53(8) 1634-1640 (1999
13. Keswani SC Pardo CA Cherry CL Hoke A McArthur JC. HIV-associated sensory neuropathies. AIDS 16(16) 2105-2117 (2002
14. Zhou L Kitch DW Evans SR et al. Correlates of epidermal nerve fiber densities in HIV-associated distal sensory polyneuropathy. Neurology 68(24) 2113-2119 (2007
15. Rance NE McArthur JC Cornblath DR Landstrom DL Griffin JW Price DL. Gracile tract degeneration in patients with sensory neuropathy and AIDS. Neurology 38(2) 265-271 (1988
16. Dorsey SG Morton PG. HIV peripheral neuropathy: pathophysiology and clinical implications. AACN Clin. Issues 17(1) 30-36 (2006
17. Manji H. Neuropathy in HIV infection. Curr. Opin. Neurol. 13(5) 589-592 (2000
18. Kennedy JM Hoke A Zhu Y et al. Peripheral neuropathy in lentivirus infection: evidence of inflammation and axonal injury. AIDS 18(9) 1241-1250 (2004
19. Pardo CA McArthur JC Griffin JW. HIV neuropathy: insights in the pathology of HIV peripheral nerve disease. J. Peripher. Nerv. Syst. 6(1) 21-27 (2001
20. Tagliati M Grinnell J Godbold J Simpson DM. Peripheral nerve function in HIV infection: clinical electrophysiologic and laboratory findings. Arch. Neurol. 56(1) 84-89 (1999
21. Zhu Y Jones G Tsutsui S et al. Lentivirus infection causes neuroinflammation and neuronal injury in dorsal root ganglia: pathogenic effects of STAT-1 and inducible nitric oxide synthase. J. Immunol. 175(2) 1118-1126 (2005
22. Araujo AP Nascimento OJ Garcia OS. Distal sensory polyneuropathy in a cohort of HIV-infected children over five years of age. Pediatrics 106(3) E35 (2000
23. Verma A. Epidemiology and clinical features of HIV-1 associated neuropathies. J. Peripher. Nerv. Syst. 6(1) 8-13 (2001
24. Fuller GN Jacobs JM Guiloff RJ. Nature and incidence of peripheral nerve syndromes in HIV infection. J. Neurol. Neurosurg. Psychiatry 56(4) 372-381 (1993
25. Rizzuto N Cavallaro T Monaco S et al. Role of HIV in the pathogenesis of distal symmetrical peripheral neuropathy. Acta. Neuropathol. 90(3) 244-250 (1995
26. Yoshioka M Shapshak P Srivastava AK et al. Expression of HIV-1 and interleukin-6 in lumbosacral dorsal root ganglia of patients with AIDS. Neurology 44(6) 1120-1130 (1994
27. Hahn K Robinson B Anderson C et al. Differential effects of HIV infected macrophages on dorsal root ganglia neurons and axons. Exp. Neurol. 210(1) 30-40 (2008
28. Scaravilli F Sinclair E Arango JC Manji H Lucas S Harrison MJ. The pathology of the posterior root ganglia in AIDS and its relationship to the pallor of the gracile tract. Acta. Neuropathol. 84(2) 163-170 (1992
29. Burdo TH Orzechowski K Knight HL Miller AD Williams K. Dorsal root ganglia damage in SIV-infected rhesus macaques: an animal model of HIV-induced sensory neuropathy. Am. J. Pathol. 180(4) 1362-1369 (2012
30. Zhu Y Antony JM Martinez JA et al. Didanosine causes sensory neuropathy in an HIV/AIDS animal model: impaired mitochondrial and neurotrophic factor gene expression. Brain 130(Pt 8) 2011-2023 (2007
31. Keswani SC Jack C Zhou C Hoke A. Establishment of a rodent model of HIV-associated sensory neuropathy. J. Neurosci. 26(40) 10299-10304 (2006
32. Wallace VC Blackbeard J Pheby T et al. Pharmacological behavioural and mechanistic analysis of HIV-1 gp120 induced painful neuropathy. Pain 133(1-3) 47-63 (2007
33. Wallace VC Blackbeard J Segerdahl AR et al. Characterization of rodent models of HIV-gp120 and anti-retroviral-associated neuropathic pain. Brain 130(Pt 10) 2688-2702 (2007
34. Bhangoo SK Ripsch MS Buchanan DJ Miller RJ White FA. Increased chemokine signaling in a model of HIV1-associated peripheral neuropathy. Mol. Pain 5,48 (2009
35. Zink MC Laast VA Helke KL et al. From mice to macaques-animal models of HIV nervous system disease. Curr. HIV Res. 4(3) 293-305 (2006
36. Laast VA Shim B Johanek LM et al. Macrophage-mediated dorsal root ganglion damage precedes altered nerve conduction in SIV-infected macaques. Am. J. Pathol. 179(5) 2337-2345 (2011
37. Laast VA Pardo CA Tarwater PM et al. Pathogenesis of simian immunodeficiency virus-induced alterations in macaque trigeminal ganglia. J. Neuropathol. Exp. Neurol. 66(1) 26-34 (2007
38. Lehmann HC Chen W Borzan J Mankowski JL Hoke A. Mitochondrial dysfunction in distal axons contributes to human immunodeficiency virus sensory neuropathy. Ann. Neurol. 69(1) 100-110 (2011
39. Jones G Zhu Y Silva C et al. Peripheral nerve-derived HIV-1 is predominantly CCR5-dependent and causes neuronal degeneration and neuroinflammation. Virology 334(2) 178-193 (2005
40. Cao L Butler MB Tan L Draleau KS Koh WY. Murine immunodeficiency virusinduced peripheral neuropathy and the associated cytokine responses. J. Immunol. 189(7) 3724-3733 (2012
41. Cao L Butler MB. Involvement of microglial CD40 in murine retrovirus-induced peripheral neuropathy. J. Neuroimmunol. 261(1-2) 37-43 (2013
42. Toggas SM Masliah E Rockenstein EM Rall GF Abraham CR Mucke L. Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature 367(6459) 188-193 (1994
43. Dorsey SG Leitch CC Renn CL et al. Genome-wide screen identifies drug-induced regulation of the gene giant axonal neuropathy (Gan) in a mouse model of antiretroviral-induced painful peripheral neuropathy. Biol. Res. Nurs. 11(1) 7-16 (2009
44. Herzberg U Sagen J. Peripheral nerve exposure to HIV viral envelope protein gp120 induces neuropathic pain and spinal gliosis. J. Neuroimmunol. 116(1) 29-39 (2001
45. Maratou K Wallace VC Hasnie FS et al. Comparison of dorsal root ganglion gene expression in rat models of traumatic and HIV-associated neuropathic pain. Eur. J. Pain 13(4) 387-398 (2009
46. Zheng W Ouyang H Zheng X et al. Glial TNFalpha in the spinal cord regulates neuropathic pain induced by HIV gp120 application in rats. Mol. Pain 7 40 (2011
47. Joseph EK Chen X Khasar SG Levine JD. Novel mechanism of enhanced nociception in a model of AIDS therapy-induced painful peripheral neuropathy in the rat. Pain 107(1-2) 147-158 (2004
48. Joseph EK Levine JD. Caspase signalling in neuropathic and inflammatory pain in the rat. Eur. J. Neurosci. 20(11) 2896-2902 (2004
49. Wallace VC Segerdahl AR Blackbeard J Pheby T Rice AS. Anxiety-like behaviour is attenuated by gabapentin morphine and diazepam in a rodent model of HIV anti-retroviral-associated neuropathic pain. Neurosci. Lett. 448(1) 153-156 (2008
50. Huang W Calvo M Karu K et al. A clinically relevant rodent model of the HIV antiretroviral drug stavudine induced painful peripheral neuropathy. Pain 154(4) 560-575 (2013
51. Bouhassira D Attal N Willer JC Brasseur L. Painful and painless peripheral sensory neuropathies due to HIV infection: a comparison using quantitative sensory evaluation. Pain 80(1-2) 265-272 (1999
52. Anderson TD Davidovich A Arceo R Brosnan C Arezzo J Schaumburg H. Peripheral neuropathy induced by 2́,3́-dideoxycytidine. A rabbit model of 2́,3́-dideoxycytidine neurotoxicity. Lab. Invest. 66(1) 63-74 (1992
53. Feldman D Brosnan C Anderson TD. Ultrastructure of peripheral neuropathy induced in rabbits by 2́,3́-dideoxycytidine. Lab. Invest. 66(1) 75-85 (1992
54. Anderson TD Davidovich A Feldman D et al. Mitochondrial schwannopathy and peripheral myelinopathy in a rabbit model of dideoxycytidine neurotoxicity. Lab. Invest. 70(5) 724-739 (1994
55. Feldman D Anderson TD. Schwann cell mitochondrial alterations in peripheral nerves of rabbits treated with 2́,3́-dideoxycytidine. Acta. Neuropathol. 87(1) 71-80 (1994
56. Warner WA Bregman CL Comereski CR et al. Didanosine (ddl) and stavudine (d4T): absence of peripheral neurotoxicity in rabbits. Food Chem. Toxicol. 33(12) 1047-1050 (1995
57. Hartmann K. Feline immunodeficiency virus infection: an overview. Vet. J. 155(2) 123-137 (1998
58. English RV Johnson CM Gebhard DH Tompkins MB. In vivo lymphocyte tropism of feline immunodeficiency virus. J. Virol. 67(9) 5175-5186 (1993
59. Beebe AM Dua N Faith TG Moore PF Pedersen NC Dandekar S. Primary stage of feline immunodeficiency virus infection: viral dissemination and cellular targets. J. Virol. 68(5) 3080-3091 (1994
60. Willett BJ Adema K Heveker N et al. The second extracellular loop of CXCR4 determines its function as a receptor for feline immunodeficiency virus. J. Virol. 72(8) 6475-6481 (1998
61. Shimojima M Miyazawa T Ikeda Y et al. Use of CD134 as a primary receptor by the feline immunodeficiency virus. Science 303(5661) 1192-1195 (2004
62. Zhu Y Antony J Liu S et al. CD8+ lymphocyte-mediated injury of dorsal root ganglion neurons during lentivirus infection: CD154-dependent cell contact neurotoxicity. J. Neurosci. 26(13) 3396-3403 (2006
63. Sasseville VG Lackner AA. Neuropathogenesis of simian immunodeficiency virus infection in macaque monkeys. J. Neurovirol. 3(1) 1-9 (1997
64. Desrosiers RC. The simian immunodeficiency viruses. Annu. Rev. Immunol. 8 557-578 (1990
65. Zink MC Suryanarayana K Mankowski JL et al. High viral load in the cerebrospinal fluid and brain correlates with severity of simian immunodeficiency virus encephalitis. J. Virol. 73(12) 10480-10488 (1999
66. Lackner AA Dandekar S Gardner MB. Neurobiology of simian and feline immunodeficiency virus infections. Brain Pathol. 1(3) 201-212 (1991
67. Lackner AA Vogel P Ramos RA Kluge JD Marthas M. Early events in tissues during infection with pathogenic (SIVmac239) and nonpathogenic (SIVmac1A11) molecular clones of simian immunodeficiency virus. Am. J. Pathol. 145(2) 428-439 (1994
68. Ratai EM Bombardier JP Joo CG et al. Proton magnetic resonance spectroscopy reveals neuroprotection by oral minocycline in a nonhuman primate model of accelerated NeuroAIDS. PLoS ONE 5(5) e10523 (2011
69. Clements JE Mankowski JL Gama L Zink MC. The accelerated simian immunodeficiency virus macaque model of human immunodeficiency virus-associated neurological disease: from mechanism to treatment. J. Neurovirol. 14(4) 309-317 (2008
70. Ebenezer GJ Laast VA Dearman B et al. Altered cutaneous nerve regeneration in a simian immunodeficiency virus/macaque intracutaneous axotomy model. J. Comp. Neurol. 514(3) 272-283 (2009
71. Dorsey JL Mangus L Oakley J Mankowski JL. Corneal sensory nerve fiber loss in SIN-infected macques tracking HIV PNS damage. Presented at: Conference on Retroviruses and Opportunistic Infections. MA USA 3-6 March 2014.
72. Westmoreland SV Halpern E Lackner AA. Simian immunodeficiency virus encephalitis in rhesus macaques is associated with rapid disease progression. J. Neurovirol. 4(3) 260-268 (1998
73. Williams K Westmoreland S Greco J et al. Magnetic resonance spectroscopy reveals that activated monocytes contribute to neuronal injury in SIV neuroAIDS. J. Clin. Invest. 115(9) 2534-2545 (2005
74. Burdo TH Soulas C Orzechowski K et al. Increased monocyte turnover from bone marrow correlates with severity of SIV encephalitis and CD163 levels in plasma. PLoS Pathog. 6(4) e1000842 (2010
75. Ratai EM Pilkenton S He J et al. CD8(+) lymphocyte depletion without SIV infection does not produce metabolic changes or pathological abnormalities in the rhesus macaque brain. J. Med. Primatol. 40(5) 300-309 (2011
76. Williams K Burdo TH. Monocyte mobilization activation markers and unique macrophage populations in the brain: observations from siv infected monkeys are informative with regard to pathogenic mechanisms of HIV infection in humans. J. Neuroimmune Pharmacol. 7(2) 363-371 (2012
77. Kim WK Sun Y Do H et al. Monocyte heterogeneity underlying phenotypic changes in monocytes according to SIV disease stage. J. Leukoc. Biol. 87(4) 557-567 (2010
78. Annamalai L Bhaskar V Pauley DR et al. Impact of short-term combined antiretroviral therapy on brain virus burden in simian immunodeficiency virus-infected and CD8+ lymphocyte-depleted rhesus macaques. Am. J. Pathol. 177(2) 777-791 (2010
79. Ratai EM Annamalai L Burdo T et al. Brain creatine elevation and N-acetylaspartate reduction indicates neuronal dysfunction in the setting of enhanced glial energy metabolism in a macaque model of NeuroAIDS. Magn. Reson. Med. 66(3) 625-634 (2011
80. Soulas C Conerly C Kim WK et al. Recently infiltrating MAC387(+) monocytes/macrophages a third macrophage population involved in SIV and HIV encephalitic lesion formation. Am. J. Pathol. 178(5) 2121-2135 (2011
81. Campbell JH Burdo TH Autissier P et al. Minocycline inhibition of monocyte activation correlates with neuronal protection in SIV neuroAIDS. PLoS ONE 6(4) e18688 (2011
82. Esiri MM Morris CS Millard PR. Sensory and sympathetic ganglia in HIV-1 infection: immunocytochemical demonstration of HIV-1 viral antigens increased MHC class II antigen expression and mild reactive inflammation. J. Neurol. Sci. 114(2) 178-187 (1993
83. Hou Q Barr T Gee L et al. Keratinocyte expression of calcitonin gene-related peptide beta: implications for neuropathic and inflammatory pain mechanisms. Pain 152(9) 2036-2051 (2011
84. Kolson DL Gonzalez-Scarano F. HIVassociated neuropathies: role of HIV-1 CMV and other viruses. J. Peripher. Nerv. Syst. 6(1) 2-7 (2001
85. Fahey MA Westmoreland SV. Nervous System Disorders of Nonhuman Primates and Research Models (2nd Edition). Elsevier London UK 738-739 (2012
86. Thormar H. Maedi-visna virus and its relationship to human immunodeficiency virus. AIDS Rev. 7(4) 233-245 (2005).